About the MPM Lab

The MPM lab is developing microsystems for the detection and characterization of personalised medicine.

 

​

We are currently focusing on:
1. The development of Integrated Biosensors for Disease Evaluation
- Bacterial targeted AIE photosensitizers synergistically promote chemotherapy for the treatment of inflammatory cancer. Chemical Engineering Journal 447, 137579. [Link]

- FlexiPulse: A machine-learning-enabled flexible pulse sensor for cardiovascular disease diagnostics, Cell Reports Physical Science 4. [Link]

- Thin and soft Ti3C2Tx MXene sponge structure for highly sensitive pressure sensor assisted by deep learning, Chemical Engineering Journal 485, 149659. [Link]

​

2. Improving patient treatment strategies and prognosis
- Label-free biosensor of phagocytosis for diagnosing bacterial infections. Biosens Bioelectron 191, 113412. [Link]

- A 6-gene panel as a signature to predict recovery from advanced heart failure using transcriptomic analysis. Genes & Diseases. [Link]

- AIEgen-deep: Deep learning of single AIEgen-imaging pattern for cancer cell discrimination and preclinical diagnosis, Biosensors and Bioelectronics, 116086. [Link]

​

3. How the microenvironment affects disease progression
- The effects of biofilms on tumor progression in a 3D cancer-biofilm microfluidic model. Biosens Bioelectron 180, 113113. [Link]

- Biofilm Potentiates Cancer-Promoting Effects of Tumor-Associated Macrophages in a 3D Multi-Faceted Tumor Model Small 453, Part 1, 28 p., 139595. [Link]

​​

4. Integrated Microsystems
- A portable purification system for the rapid removal of microplastics from environmental samples. Chemical Engineering Journal 428, 132614. [Link]

- A deformability-based biochip for precise label-free stratification of metastatic subtypes using deep learning, Microsystems & Nanoengineering 9 (1), 120. [Link]